U.S. Ambassador Nikki Haley to the UN. Photo: Nicholas Kamm/AFP

President Trump has accepted Nikki Haley’s resignation as UN Ambassador, the two said Tuesday morning in a public Oval Office meeting. She will exit at the end of the year, Trump said, and he plans to decide on a replacement in the coming weeks.

What we're hearing: Haley discussed her resignation with Trump last week when she visited him at the White House, two sources said. Her news shocked a number of senior foreign policy officials in the Trump administration. 

Axios was first to report the resignation earlier in the day.

Trump told reporters Tuesday that Haley raised the possibility of taking a break six months ago, and that she's welcome back at any time.

  • Haley, for her part, added that she has no 2020 ambitions and will campaign for the president.

Background: Haley, the former governor of South Carolina, was easily confirmed four days after President Trump's inauguration in 2017.

She has overseen Trump's shift in dealing with the UN, including the U.S. exit from the UN Human Rights Council, which Haley called the organization's "greatest failure."

Worth noting: Haley wrote a public op-ed in September challenging the N.Y. Times' anonymous op-ed, which was written by a "senior administration official" and claimed that Trump aides saw him as a threat to U.S. democracy.

Haley wrote in her response:

  • "I don’t agree with the president on everything. When there is disagreement, there is a right way and a wrong way to address it. I pick up the phone and call him or meet with him in person."
  • "Like my colleagues in the Cabinet and on the National Security Council, I have very open access to the president. He does not shut out his advisers, and he does not demand that everyone agree with him. I can talk to him most any time, and I frequently do."
  • "If I disagree with something and believe it is important enough to raise with the president, I do it. And he listens."

Editor's Note: Get more stories like this in our weekly political lookahead newsletter, Axios Sneak Peek. Sign up here.

Go deeper

Updated 1 hour ago - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Global: Total confirmed cases as of 6 p.m. ET: 13,203,571 — Total deaths: 575,201 — Total recoveries — 7,331,068Map.
  2. U.S.: Total confirmed cases as of 6 p.m. ET: 3,407,798 — Total deaths: 136,252 — Total recoveries: 1,031,939 — Total tested: 41,004,275Map.
  3. Politics: Biden welcomes Trump wearing mask in public but warns "it’s not enough"
  4. Public health: Four former CDC heads say Trump's undermining of agency puts lives at risk — CDC director: U.S. could get coronavirus "under control" in 4–8 weeks if all wear masks.

Bank CEOs brace for worsening economic scenario

JPMorgan CEO Jamie Dimon. Photo: J. Lawler Duggan/For The Washington Post via Getty Images

Wells Fargo swung to its first loss since the financial crisis — while JPMorgan Chase and Citigroup reported significantly lower profits from a year earlier — as the banks set aside billions of dollars more in the second quarter for loans that may go bad.

Why it matters: The cumulative $28 billion in loan loss provisions that banks have so far announced they’re reserving serves as a signal they’re preparing for a colossal wave of loan defaults as the economy slogs through a coronavirus-driven downturn.

2 hours ago - Health

Moderna's vaccine spurred immune system response to coronavirus

Moderna's stock rose 16% after hours on this news. Photo: Jakub Porzycki/NurPhoto via Getty Images

Healthy volunteers who took Moderna's coronavirus vaccine candidate appeared to generate an immune system response to the virus, and there were "no trial-limiting safety concerns," according to a new study published in the New England Journal of Medicine.

Why it matters: The phase one trial is still small and does not definitively determine how effective the vaccine is. But Anthony Fauci of the National Institutes of Health, which is running the trial, told the Wall Street Journal that these data make it "pretty clear that this vaccine is capable of inducing quite good [levels] of neutralizing antibodies."